Jak2 is essential for signaling through a variety of cytokine receptors

Cell

Volumn 93, Issue 3, 1998, Pages 385-395

  Parganas, Evan ^a   Wang, Demin ^a   Stravopodis, Dimitrios ^a   Topham, David J ^a   Marine, Jean Christophe ^a   Teglund, Stephan ^a   Vanin, Elio F ^a   Bodner, Sara ^a   Colamonici, Oscar R ^b   Van Deursen, Jan M ^a   Grosveld, Gerard ^a   Ihle, James N ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; CYTOKINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; PROTEIN TYROSINE KINASE; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EMBRYO; EMBRYO DEATH; ERYTHROPOIESIS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS;

EID: 0032076542     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81167-8     Document Type: Article

References (58)

1. Andus, T., Geiger, T., Hirano, T., Kishimoto, T., and Heinrich, P.C. (1988). Action of recombinant human interleukin 6, interleukin 1 beta and proteins. Eur. J. Immunol. 18, 739-746.
2. Artgetsinger, L.S., Campbell, G.S., Yang, X., Witthuhn, B.A., Silvennoinen, O., Ihle, J.N., and Carter-Su, C. (1993). Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
3. Bacon, C.M., McVicar, D.W., Ortaldo, J.R., Rees, R.C., O'Shea, J.J., and Johnston, J.A. (1995). Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181, 399-404.
4. Barge, R.M., de Koning, J.P., Pouwels, K., Dong, F., Lowenberg, B., and Touw, I.P. (1996). Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood 87, 2148-2153.
5. Campbell, G.S., Argetsinger, L.S., Ihle, J.N., Kelly, P.A., Rillema, J.A., and Carter-Su, C. (1994). Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. USA 91, 5232-5236.
6. Drachman, J.G., Griffin, J.D., and Kaushansky, K. (1995).The c-mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-mpl. J. Biol. Chem. 270, 4979-4982.
7. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R., and Krolewski, J.J. (1990). Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5, 1329-1336.
8. Guschin, D., Rogers, N., Briscoe, J., Witthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G.R., Ihle, J.N., and Kerr, I.M. (1995). A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14, 1421-1429.
9. Hanazono, Y., Chiba, S., Sasaki, K., Mano, H., Yazaki, Y., and Hirai, H. (1993). Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 81, 3193-3196.
10. Hirota, H., Yoshida, K., Kishimoto, T., and Taga, T. (1995). Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92, 4862-4866.
11. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manipulating the Mouse Embryo: A Laboratory Manual, Second Edition (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press).
12. Ihle, J.N. (1995). Cytokine receptor signalling. Nature 377, 591-594.
13. Kieran, M.W., Perkins, A.C., Orkin, S.H., and Zon, L.I. (1996). Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 93, 9126-9131.
14. Leonard, W.J., Shores, E.W., and Love, P.E. (1995). Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 148, 97-114.
15. Macchi, P., Villa, A., Giliani, S., Sacco, M.G., Frattini, A., Porta, F., Ugazio, A.G., Johnston, J.A., Candotti, F., O'Shea, J.J., Vezzoni, P., and Notarangelo, L.D. (1995). Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65-68.
16. Machide, M., Mano, H., and Todokoro, K. (1995). Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11, 619-625.
17. Mano, H., Yamashita, Y., Sato, K., Yazaki, Y., and Hirai, H. (1995). Tec protein-tryosine kinase is involved in interleukin-3 signaling pathway. Blood 85, 343-350.
18. Miyakawa, Y., Oda, A., Druker, B.J., Kato, T., Miyazaki, H., Handa, M., and Ikeda, Y. (1995). Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase2 and Shc inhuman blood platelets. Blood 86, 23-27.
19. Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner, C.M., Miller, T.A., Peitryga, D.W., Scott, W., Jr., and Potter, S.S. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689.
20. Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A.G., Barbieri, G., Witthuhn, B.A., Schindler, C., et al. (1993). The protein tyrosine kinase JAK1 complements defects in interferon-α/β and γ-signal transduction. Nature 366, 129-135.
21. Narazaki, M., Witthuhn, B.A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J.N., Kishimoto, T., and Taga, T. (1994). Activation of JAK2 kinase mediated by the IL-6 signal transducer, gp130. Proc. Natl. Acad. Sci. USA 91, 2285-2289.
22. Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., and Pfeffer, K. (1998). Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, this issue, 397-409.
23. Nicholson, S.E., Oates, A.C., Harpur, A.G., Ziemiecki, A., Wilks, A.F., and Layton, J.E. (1994). Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91, 2985-2988.
24. MAPK. Blood 86, 3698-3704.
25. Nosaka, T., van Deursen, J.M.A., Tripp, R.A., Thierfelder, W.E., Witthuhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1995). Defective lymphoid development in mice lacking Jak3. Science 270, 800-802.
26. Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R., and Grosveld, F. (1995). Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375, 316-318.
27. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
28. Perkins, A.C., Sharpe, A.H., and Orkin, S.H. (1995). Lethal beta-thalassaemiain mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375, 318-322.
29. Pevny, L., Simon, M.C., Robertson, E., Klein, W.H., Tsai, S.-F., D'Agati, V., Orkin, S.H., and Costantini, F. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260.
30. Rauprich, P., Kasper, B., Tidow, N., and Welte, K. (1995).The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 86, 4500-4505.
31. Rodig, S.J., Meraz, M.A., White, M., Lampe, P.A., Riley, J.K., Arthur, C.D., King, K.L., Sheeehan, K.C.F., Yin, L., Pennica, D., Johnson, E.M., Jr., and Schreiber, R.D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, this issue, 373-383.
32. Russell, S.M., Tayebi, N., Nakajima, H., Riedy, M.C., Roberts, J.L., Aman, M.J., Migone, T.-S., Noguchi, M., Markert, M.L., Buckley, R.H., O'Shea, J.J., and Leonard, W.J. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800.
33. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory).
34. Scott, E.W., Simon, M.C., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577.
35. Shimoda, K., Iwasaki, H., Okamura, S., Ohno, Y., Kubota, A., Arima, F., Otsuka, T., and Niho, Y. (1994). G-CSF induces tyrosine phosphorylation of the Jak2 protein in the human myeloid G-CSF responsive and proliferative cells, but not in mature neutrophiles. Biochem. Biophys. Res. Commun. 203, 922-928.
36. Shimoda, K., Feng, J., Murakami, H., Nagata, S., Watling, D., Rogers, N.C., Stark, G.R., Kerr, I.M., and Ihle, J.N. (1997). Jak1 plays an essential role for receptor phosphorylation and stat activation in response to granulocyte colony-stimulating factor. Blood 90, 597-604.
37. Silvennoinen, O., Witthuhn, B., Quelle, F.W., Cleveland, J.L., Yi, T., and Ihle, J.N. (1993). Structure of the JAK2 protein tyrosine kinase and its role in IL-3 signal transduction. Proc. Natl. Acad. Sci. USA 90, 8429-8433.
38. Stahl, N., Boulton, T.G., Farruggella, T., Ip, N.Y., Davis, S., Witthuhn, B.A., Quelle, F.W., Silvennoinen, O., Barbieri, G., Pellegrini, S., Ihle, J.N., and Yancopoulos, G.D. (1994). Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263, 92-95.
39. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H., and Berg, L.J. (1995). Mice lacking Jak3 have defects in B lymphocyte maturation and T lymphocyte activation. Science 270, 794-797.
40. Torigoe, T., O'Connor, R., Santoli, D., and Reed, J.C. (1992a). Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood 80, 617-624.
41. Torigoe, T., O-Connor, R., Fagard, R., Fischer, S., Santoli, D., and Reed, J.C. (1992b). Regulation of SRC-family protein tyrosine kinases by interleukins, IL-2, and IL-3. Leukemia 6 (Suppl 3), 94S-97S.
42. Tortolani, P.J., Johnston, J.A., Bacon, C.M., McVicar, D.W., Shimosaka, A., Linnekin, D., Longo, D.L., and O'Shea, J.J. (1995). Thrombopoietin induces tyrosine phosphorylation and activation of the janus kinase, JAK2. Blood 85, 3444-3451.
43. Tsai, F.-Y., Keller, G., Kuo, F.C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F.W., and Orkin, S.H. (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371, 221-226.
44. Tsubokawa, M., Tohyama, Y., Tohyama, K., Asahi, M., Inazu, T., Nakamura, H., Saito, H., and Yamamura, H. (1997). Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML 193. Eur. J. Biochem. 249, 792-796.
45. van Deursen, J., Lovell-Badge, R., Oerlemans, F., Schepens, J., and Wieringa, B. (1991). Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells. Nucleic Acids Res. 19, 2637-2643.
46. van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap, P., ter Laak, H., and Wieringa, B. (1993). Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74, 621-631.
47. Velazquez, L., Fellous, M., Stark, G.R., and Pellegrini, S. (1992). A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70, 313-322.
48. von Freeden-Jeffry, U., Vieria, P., Lucian, L.A., McNeil, T., Burdach, S.E.G., and Murray, R. (1995). Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
49. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J.N. (1996). Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16, 6141-6148.
50. Warren, A.J., Colledge, W.H., Carlton, M.B., Evans, M.J., Smith, A.J., and Rabbitts, T.H. (1994). The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78, 45-57.
51. Watling, D., Guschin, D., Muller, M., Silvennoinen, O., Witthuhn, B.A., Quelle, F.W., Rogers, N.C., Schindler, C., Stark, G.R., Ihle, J.N., and Kerr, I.M. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 366, 166-170.
52. Whitelaw, E., Tasi, S.-F., Hogben, P., and Orkin, S.H. (1990). Regulated expression of globin chains and the erythroid transcription factor GATA-1 during erythropoiesis in the developing mouse. Mol. Biol. Cell 10, 6596-6606.
53. Wilks, A.F. (1991). Cloning members of protein-tyrosine kinase family using polymerase chain reaction. Meth. Enzymol. 200, 533-546.
54. Witthuhn, B., Quelle, F.W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., and Ihle, J.N. (1993). JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following EPO stimulation. Cell 74, 227-236.
55. Wollert, K.C., and Chien, K.R. (1997). Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J. Mol. Med. 75, 492-501.
56. Wu, H., Klingmuller, U., Besmer, P., and Lodish, H.F. (1995a). Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377, 242-246.
57. Wu, H., Liu, X., Jaenisch, R., and Lodish, H.F. (1995b). Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67.
58. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-411.